Court Upholds Martin Shkreli's Lifetime Pharma Ban; Cited in Trump Real Estate Case

New York Attorney General Letitia James uses Shkreli's case as precedent in her bid to ban former President Donald Trump from the New York real estate industry.

Martin Shkreli's lifetime ban from the pharmaceutical industry was upheld by a federal appeals court, which ruled that the ban was a reasonable measure to protect the public from future price-fixing.
Shkreli was ordered to repay $64.6 million for his role in orchestrating an illegal anticompetitive scheme, which involved increasing the price of the antiparasitic drug Daraprim by 4,000%.
New York Attorney General Letitia James cited the ruling in her case against former President Donald Trump, in which she is seeking a lifetime ban for Trump from the New York real estate industry.
James is alleging that Trump and his associates fraudulently inflated the former president's assets by billions of dollars on statements of financial condition.
The case against Trump is still pending, with the judge yet to issue a ruling on the attorney general's request.